Hillsdale Investment Management »

Oramed Pharm shares owned by Hillsdale Investment Management

Quarter-by-quarter ownership of Oramed Pharm (ORMP) shares owned by Hillsdale Investment Management from 13F filings

Historical chart of Hillsdale Investment Management investment in Oramed Pharm

Tip: Access up to 7 years of quarterly data

All positions including Oramed Pharm held by Hillsdale Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oramed Pharm by Hillsdale Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $331k 97k 3.40

More positions owned by Hillsdale Investment Management

Rbc Cad (RY)
Cibc Cad (CM)
Tor Dom Bk Cad (TD)
Bk Nova Cad (BNS)
Enerflex (EFXT)
Agnico (AEM)
Bank Of Montreal Cadcom (BMO)
Manulife Finl Corp (MFC)
Fortis (FTS)
Centerra Gold (CGAU)
Barrick Mining Corp (B)
Precision Drill (PDS)
Enbridge (ENB)
NVIDIA Corporation (NVDA)
Suncor Energy (SU)

View all positions for Hillsdale Investment Management

Top funds holding Oramed Pharm

BML Capital Management
Aquamarine Financial
Mercer Global Advisors
SB Capital Management
Murchinson
Boothbay Fund Management
Marshall Wace
Rathbones Brothers
Dimensional Fund Advisors
Wells Fargo & Company
Comprehensive Portfolio Management
Renaissance Technologies
Bank of America Corporation
Susquehanna International
O'shaughnessy Asset Management

View all funds holding Oramed Pharm